Margaret Pax
Vermögen: 424 581 $ am 31.07.2026
Vermögen: 424 581 $ am 31.07.2026
Ms. Margaret A. Pax is an Independent Director at Repligen Corp.
and an Independent Director at Jellagen Pty Ltd. She is on the Board of Directors at Repligen Corp., BioPorto, Inc., Harvard Business School Health Industry Alumni Association and Jellagen Pty Ltd. Ms. Pax was previously employed as an Independent Director by Alimera Sciences, Inc., a Vice President-Business Development by Microchips Biotech, Inc., and a Vice President-Marketing by OmniSonics Medical Technologies, Inc. She also served on the board at Bioporto A/S.
She received her undergraduate degree from the College of the Holy Cross (Massachusetts) and an MBA from Harvard Business School.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
REPLIGEN CORPORATION 0.01% | 14.05.2026 | 3’011 ( 0.01% ) | 424 581 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| REPLIGEN CORPORATION | Direktor/Vorstandsmitglied | 18.03.2024 |
Bioporto, Inc. | Direktor/Vorstandsmitglied | - |
Jellagen Pty Ltd.
Jellagen Pty Ltd. Food: Meat/Fish/DairyConsumer Non-Durables Produces research grade functional non-mammalian collagen products | Direktor/Vorstandsmitglied | - |
Harvard Business School Health Industry Alumni Association | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| ALIMERA SCIENCES, INC. | Direktor/Vorstandsmitglied | 16.09.2024 |
| BIOPORTO A/S | Direktor/Vorstandsmitglied | - |
OmniSonics Medical Technologies, Inc.
OmniSonics Medical Technologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Vertrieb & Marketing | - |
Microchips Biotech, Inc.
Microchips Biotech, Inc. Pharmaceuticals: MajorHealth Technology Develops drug delivery systems and biosensing devices | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Repligen Corp.
Repligen Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures biologic drugs | Health Technology |
Alimera Sciences, Inc.
Alimera Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops, manufactures and commercializes therapeutics for ophthalmology, rheumatology, nephrology, neurology & pulmonology problems | Health Technology |
OmniSonics Medical Technologies, Inc.
OmniSonics Medical Technologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Bioporto A/S
Bioporto A/S Medical SpecialtiesHealth Technology Develops and markets human and animal neutrophil gelatinase-associated lipocalin antibodies kits | Health Technology |
College of the Holy Cross (Massachusetts)
College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Microchips Biotech, Inc.
Microchips Biotech, Inc. Pharmaceuticals: MajorHealth Technology Develops drug delivery systems and biosensing devices | Health Technology |
Harvard Business School Health Industry Alumni Association | |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jellagen Pty Ltd.
Jellagen Pty Ltd. Food: Meat/Fish/DairyConsumer Non-Durables Produces research grade functional non-mammalian collagen products | Consumer Non-Durables |
Bioporto, Inc. |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen